Literature DB >> 2178329

The glucose transporter and blood-brain barrier of human brain tumors.

C Guerin1, J Laterra, R H Hruban, H Brem, L R Drewes, G W Goldstein.   

Abstract

The glucose transporter of the human brain has been localized to endothelial cells expressing the blood-brain barrier, but little is known regarding its mechanism of induction or whether its expression is exclusively linked with restricted vascular permeability. We investigated glucose transporter expression by vessels in human astrocytic tumors and pulmonary metastases to the brain using immunohistochemical techniques. Vessels in 9 of 10 low-grade astrocytomas and 8 of 10 anaplastic astrocytomas were positive for glucose transporter. Glioblastoma vessels were transporter-positive in only 2 of 10 specimens. Vessels in all three metastatic tumors were negative for the glucose transporter. The decrease in transporter expression observed in higher-grade tumors occurred independently of increases in vascular permeability. In low-grade astrocytomas and glioblastomas transporter expression and contrast enhancement were inversely related, but vessels in 6 of 9 anaplastic astrocytomas were transporter-positive despite contrast enhancement. These findings suggest that separate mechanisms induce the glucose transporter and the permeability restrictions of the human blood-brain barrier. They also have potential implications for the therapy and prognosis of astroglial neoplasms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2178329     DOI: 10.1002/ana.410280606

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  19 in total

1.  Neurons and microvessels express the brain glucose transporter protein GLUT3.

Authors:  D Z Gerhart; M A Broderius; N D Borson; L R Drewes
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

Review 2.  Insulin-like growth factors in central nervous system tumors.

Authors:  R P Glick; T Lichtor; T G Unterman
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

3.  Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements.

Authors:  Mahsa Eskian; Abass Alavi; MirHojjat Khorasanizadeh; Benjamin L Viglianti; Hans Jacobsson; Tara D Barwick; Alipasha Meysamie; Sun K Yi; Shingo Iwano; Bohdan Bybel; Federico Caobelli; Filippo Lococo; Joaquim Gea; Antonio Sancho-Muñoz; Jukka Schildt; Ebru Tatcı; Constantin Lapa; Georgia Keramida; Michael Peters; Raef R Boktor; Joemon John; Alexander G Pitman; Tomasz Mazurek; Nima Rezaei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-22       Impact factor: 9.236

4.  Immunohistochemical expression of glucose transporter-1 in human penile proliferative lesions.

Authors:  N Moriyama; S Kurimoto; K Kawabe; K Takata; H Hirano
Journal:  Histochem J       Date:  1997-04

Review 5.  Vascular microenvironment in gliomas.

Authors:  P Vajkoczy; M D Menger
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 6.  In vitro blood-brain barrier models: current and perspective technologies.

Authors:  Pooja Naik; Luca Cucullo
Journal:  J Pharm Sci       Date:  2011-12-27       Impact factor: 3.534

Review 7.  The blood-brain barrier: cellular basis.

Authors:  R C Janzer
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

Review 8.  In vitro cerebrovascular modeling in the 21st century: current and prospective technologies.

Authors:  Christopher A Palmiotti; Shikha Prasad; Pooja Naik; Kaisar M D Abul; Ravi K Sajja; Anilkumar H Achyuta; Luca Cucullo
Journal:  Pharm Res       Date:  2014-08-07       Impact factor: 4.200

9.  Dexamethasone selectively regulates the activity of enzymatic markers of cerebral endothelial cell lines.

Authors:  L Juillerat-Jeanneret; A Aguzzi; O D Wiestler; P Darekar; R C Janzer
Journal:  In Vitro Cell Dev Biol       Date:  1992 Jul-Aug

10.  Vascular expression of glucose transporter in experimental brain neoplasms.

Authors:  C Guerin; J Laterra; L R Drewes; H Brem; G W Goldstein
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.